| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
ARTICLES |
Animal Reproduction and Biotechnology Laboratory, Department of Physiology, Colorado State University, Fort Collins, Colorado 80523
Address all correspondence and requests for reprints to: Dr. Terry Nett, Animal Reproduction and Biotechnology Laboratory, Colorado State University, Fort Collins, Colorado 80523. E-mail: tnett{at}colostate.edu
| Abstract |
|---|
|
|
|---|
Treatment with GnRH and estradiol also influenced the expression of genes encoding the LHß and FSHß subunits. Compared with saline-treated controls, treatment with GnRH reduced steady-state amounts of mRNA encoding LHß subunit (P < 0.005) and FSHß subunit (P < 0.05). Treatment with estradiol caused a decrease in concentrations of FSHß subunit mRNA (P < 0.01) but did not affect amounts of LHß subunit mRNA. The combined treatment of GnRH and estradiol reduced concentrations of mRNA encoding LHß subunit (P < 0.01) and FSHß subunit (P < 0.005).
From these data we conclude that 1) reduced numbers of GnRH receptors during continuous infusion of GnRH are mediated in part by decreased expression of the GnRH receptor gene; and 2) estradiol is able to override the negative effect of GnRH by stimulating an increase in GnRH receptor gene expression and GnRH receptor concentrations. Therefore, although the gonadotrope becomes refractory to GnRH during homologous desensitization, this desensitization does not affect the cells ability to respond to estradiol.
| Introduction |
|---|
|
|
|---|
Another important endocrine regulator of ovine GnRH receptors is estradiol. Treatment with estradiol consistently increases GnRH receptor gene expression and numbers of GnRH receptors in vivo (4, 10, 11) and in cultured pituitary cells (12, 13, 14). In the ewe, estradiol stimulates expression of the GnRH receptor gene and numbers of GnRH receptors in the absence of GnRH (5), thus indicating that this effect of estradiol is exerted directly at the pituitary level. Because GnRH and estradiol both regulate concentrations of GnRH receptor, it is likely that the interaction of these hormones has important effects on the sensitivity of gonadotropes and, ultimately, the regulation of gonadotropin secretion. However, the interaction of GnRH and estradiol in regulating GnRH receptor is not well understood. Because estradiol affects its target cells via an intracellular receptor, whereas GnRH binds to receptors on the plasma membrane, it is assumed that these hormones influence GnRH receptor synthesis by different cellular mechanisms. In the present study, the potential for estradiol to override the negative effect of continuous infusion of GnRH on expression of GnRH receptors was addressed. Our objectives were to: 1) characterize changes in steady-state concentrations of mRNA encoding GnRH receptor and numbers of GnRH receptors following continuous infusion of GnRH; and 2) measure effects of estradiol on concentrations of GnRH receptor mRNA and numbers of GnRH receptors after desensitization of the anterior pituitary gland by GnRH.
| Materials and Methods |
|---|
|
|
|---|
Analysis of mRNA
Polyadenylated (poly A+) RNA was prepared from one half of each
pituitary gland (15). Integrity of this RNA was verified with Northern
blot analysis of mRNA encoding GnRH receptor, and steady-state
concentrations of mRNA encoding GnRH receptor and gonadotropin subunits
were quantified by slot blot analysis as described previously (11).
Briefly, 1.5 µg of poly A+ RNA were immobilized in duplicate on a
nylon membrane (Hybond; Amersham, Arlington Heights, IL),
cross-linked by exposure to UV light (Stratagene, La
Jolla, CA), and probed with complementary DNAs for ovine GnRH receptor
(11), bovine LHß subunit (16), bovine FSHß subunit (17), and bovine
-subunit (18). After hybridization, the final washes were in
0.5 x SSC (750 mM NaCl and 75 mM Na
citrate), 0.1% SDS at 65 C. The nylon membrane was exposed to
Hyperfilm MP (Amersham) for 4 days (GnRH receptor and FSHß subunit),
7.5 h (LHß-subunit), or 8 h (
-subunit). After quantities
of GnRH receptor and gonadotropin subunit mRNAs were analyzed, the
membrane was stripped of radiolabeled complementary DNA and reprobed
with radiolabeled dT (18 mer) as described by Juengel et al.
(19). Autoradiographs were analyzed with the NIH 1.52 Image Analysis
Program. Concentrations of mRNA were normalized to the amount of poly
A+ RNA in each sample and expressed as percent of control values.
Hormone and receptor assays
Circulating concentrations of LH (20) and FSH (21) were
determined by RIA using NIH-oLH-S24 and NIH-oFSH-S12 as reference
preparations, respectively. Mean limit of detection, intraassay
coefficient of variation (CV), and interassay CV were 127 pg/ml, 11.4%
and 11.4%, respectively, for the LH assay and 6.0 ng/ml, 10.3%, and
10.8%, respectively, for the FSH assay.
Numbers of GnRH receptors were quantified using a standard curve technique (8). The concentration of GnRH receptors in a pool of bovine pituitary membranes was determined by Scatchard analysis. A standard curve was generated by incubating increasing quantities of the membrane pool with 0.2 nM [125I]D-Ala6-GnRH-Pro9-ethyl-amide ([125I]D-Ala6). Partially purified membranes prepared from each experimental pituitary gland were incubated with 0.2 nM [125I]D-Ala6 in assay buffer [10 mM Tris base, 1 mM CaCl2, 0.1% BSA] for 4 h on ice. At the end of the incubation, tubes were centrifuged immediately after the addition of 3 ml of ice-cold assay buffer. Amounts of specifically bound [125I]D-Ala6 in the pellets were compared with the standard curve, and the number of GnRH receptors in each sample was calculated. All samples were quantified in a single assay.
Statistical analyses
Differences in serum concentrations of LH and FSH were
determined by ANOVA for repeated measures. Steady-state concentrations
of mRNAs for GnRH receptor, gonadotropin subunits, and numbers of
GnRH receptors were analyzed using one-way ANOVA. Heterogenous
variances were corrected by log-transformation of data before ANOVA.
When significant effects of treatment were observed, means were
separated using least significant differences. Pearson correlation
coefficient (r) was computed to describe the relationship between
concentrations of mRNA for GnRH receptor and numbers of GnRH receptors.
All analyses were performed using SAS (22). Data are presented as
mean ± SEM.
| Results |
|---|
|
|
|---|
|
GnRH receptor mRNA and GnRH receptor concentrations
Figure 2
illustrates mean
concentrations of mRNA encoding GnRH receptor and numbers of GnRH
receptors. Relative to control values, amounts of GnRH receptor mRNA
and concentrations of GnRH receptor in ewes treated continuously with
GnRH decreased by 48% (P < 0.01) and 69%
(P < 0.05), respectively. Treatment with estradiol
increased the amount of mRNA encoding GnRH receptor and concentrations
of GnRH receptor by 1.6-fold (P < 0.05) and 1.9-fold
(P < 0.01), respectively. Concentrations of GnRH
receptor mRNA in ewes treated with GnRH and estradiol were similar to
those in controls but elevated 2.2-fold relative to amounts in ewes
treated only with GnRH (P < 0.001). Similarly, numbers
of GnRH receptors in ewes treated with GnRH and estradiol were elevated
by 4.6-fold relative to ewes treated only with GnRH (P
< 0.005). Concentrations of GnRH receptor were correlated to amounts
of GnRH receptor mRNA (r = 0.78, P < 0.0001).
|
subunit mRNA (Fig. 3
|
| Discussion |
|---|
|
|
|---|
Pituitary desensitization induced by continuous treatment with GnRH is marked by decreased tissue concentrations of GnRH receptors (8, 9, 23). To determine whether this reduction is mediated by decreased expression of the GnRH receptor gene, we measured steady-state concentrations of mRNA encoding GnRH receptor and found that amounts of GnRH receptor mRNA were decreased by continuous GnRH treatment. Reduced GnRH receptor gene expression has also been observed following treatment of sheep with synthetic GnRH agonists (14, 24). However, these agonists are much more potent than GnRH, and the present study is the first to characterize GnRH receptor gene expression following continuous treatment with native GnRH. GnRH receptors are internalized after binding GnRH (25, 26), and the reduction in numbers of GnRH receptors caused by continuous GnRH treatment likely reflects this internalization. However, evidence that amounts of mRNA encoding GnRH receptor also decrease following continuous treatment with GnRH indicates that desensitization of gonadotropes is not due solely to GnRH receptor internalization, but is also mediated by decreased expression of the GnRH receptor gene.
In accordance with previous reports, treatment of ovariectomized ewes with estradiol increased concentrations of GnRH receptor (4, 10, 27) and amounts of GnRH receptor mRNA (5, 11, 28). Concentrations of GnRH receptor mRNA and GnRH receptors in ewes pretreated with GnRH were not increased by estradiol compared with saline-treated controls but were significantly elevated over values in ewes treated only with GnRH. These observations indicate that continuous delivery of GnRH resulted in a new, lower baseline of GnRH receptor gene expression and numbers of GnRH receptors. From this new baseline, treatment with estradiol was still effective in stimulating GnRH receptor gene expression and numbers of GnRH receptors despite desensitization of the pituitary gland to GnRH. Increased numbers of GnRH receptors have been observed previously in estradiol-treated ewes following infusion of GnRH (29), and the present study extends those observations by showing that estradiol also stimulates GnRH receptor gene expression in the face of pituitary desensitization by GnRH. Similarly, treatment with estradiol increased amounts of GnRH receptor mRNA and restored GnRH receptor concentrations in ewes chronically treated with GnRH agonist (24). Because estradiol is effective in overriding negative effects of continuous GnRH on GnRH receptor gene expression and numbers of GnRH receptors, we suggest that estradiol increases synthesis of GnRH receptors faster than continuous infusion of GnRH causes receptor internalization, resulting in a net increase in receptor numbers.
As we have reported previously (29), increased secretion of LH in response to treatment with estradiol occurred sooner in GnRH-treated ewes compared with saline-treated ewes. In both saline- and GnRH-treated ewes, estradiol stimulated GnRH receptor gene expression and (presumably) de novo synthesis of GnRH receptors. Once inserted into the plasma membrane of gonadotropes, these receptors could immediately bind the excess exogenous GnRH present in GnRH-treated ewes and initiate LH secretion. In contrast, newly synthesized receptors in saline-treated ewes did not have immediate access to elevated concentrations of GnRH because of the time required for estradiol to stimulate endogenous GnRH secretion from the hypothalamus. Therefore, the more rapid response to estradiol following treatment with GnRH can be explained by the fact that the pituitary glands in GnRH-treated ewes were exposed to high concentrations of exogenous GnRH at the time of estradiol injection.
In addition to effects on GnRH receptor gene expression, treatment with
GnRH and/or estradiol also affected amounts of mRNA encoding the
gonadotropin subunits. In a recent study, we found that quantities of
LHß and FSHß subunit mRNA, but not
-subunit mRNA, were reduced
in cows by continuous infusion of GnRH (23). Similarly, chronic
treatment of ewes with GnRH agonist decreased amounts of LHß subunit
mRNA (24). Therefore, decreased expression of genes encoding LHß and
FSHß subunit following continuous treatment with GnRH in the present
study agrees well with previous results in domestic ruminants.
Treatment with estradiol decreased expression of the FSHß subunit
gene but did not affect quantities of
subunit mRNA or LHß subunit
mRNA. Suppressive effects of estradiol on FSHß subunit gene
expression in ewes have been observed previously (30, 31, 32). Although
decreased expression of
and LHß subunit genes after acute
treatment of ovariectomized ewes has been reported (32), Hamernik and
Nett (30) found that expression of these genes was reduced during the
decreasing portion of the LH surge but not the increasing portion. In
the present study, serum concentrations of LH were rising in
estradiol-treated ewes at the time of pituitary collection. Therefore,
the lack of effect of estradiol on quantities of
and LHß subunit
mRNA can be explained by the fact that tissues were collected during
the period of positive feedback by estradiol. In the absence of an
effect of estradiol on LHß subunit gene expression, mean quantities
of LHß subunit mRNA were similar in ewes treated with GnRH and those
treated with GnRH and estradiol. The greater magnitude of decrease in
amounts of FSHß subunit mRNA in ewes that received GnRH and estradiol
likely reflects additive negative regulation by GnRH and estradiol.
Inhibition of the reproductive axis with GnRH agonists is used in clinical settings to treat several diseases including endometriosis, uterine fibroid tumors, precocious puberty, and prostate cancer (33). Unfortunately, long-term administration of GnRH agonists has serious side effects such as accelerated bone loss and menopausal-like symptoms. To combat these side effects, estrogen replacement therapy is often prescribed (33, 34). Results of the present study indicate that although the gonadotrope becomes refractory to GnRH during homologous desensitization, this desensitization does not affect the cells ability to respond to estradiol. Consequently, it is possible that therapy with exogenous estradiol may undermine the desired effects of continuous treatment with GnRH analogs. This interaction of estradiol and GnRH on GnRH receptors may have important implications and should be considered in current clinical applications of GnRH agonists and estrogen replacement therapy.
| Acknowledgments |
|---|
| Footnotes |
|---|
2 Supported by the United States Air Force. ![]()
Received June 11, 1998.
| References |
|---|
|
|
|---|
-subunit of bovine glycoprotein hormones. Biochemistry 22:48564860[CrossRef][Medline]
This article has been cited by other articles:
![]() |
J. A. Arreguin-Arevalo, T. L. Davis, and T. M. Nett Differential Modulation of Gonadotropin Secretion by Selective Estrogen Receptor 1 and Estrogen Receptor 2 Agonists in Ovariectomized Ewes Biol Reprod, August 1, 2007; 77(2): 320 - 328. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Levavi-Sivan, J. Biran, and E. Fireman Sex Steroids Are Involved in the Regulation of Gonadotropin-Releasing Hormone and Dopamine D2 Receptors in Female Tilapia Pituitary Biol Reprod, October 1, 2006; 75(4): 642 - 650. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Arreguin-Arevalo and Terry. M. Nett A Nongenomic Action of Estradiol as the Mechanism Underlying the Acute Suppression of Secretion of Luteinizing Hormone in Ovariectomized Ewes Biol Reprod, January 1, 2006; 74(1): 202 - 208. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.L. Crawford, J.R. McNeilly, and A.S. McNeilly No Evidence for Pituitary Priming to Gonadotropin-Releasing Hormone in Relation to Luteinizing Hormone (LH) Secretion Prior to the Preovulatory LH Surge in Ewes Biol Reprod, July 1, 2004; 71(1): 224 - 235. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Levavi-Sivan, H. Safarian, H. Rosenfeld, A. Elizur, and A. Avitan Regulation of Gonadotropin-Releasing Hormone (GnRH)-Receptor Gene Expression in Tilapia: Effect of GnRH and Dopamine Biol Reprod, June 1, 2004; 70(6): 1545 - 1551. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. K. Kane, D. E. Hawkins, G. D. Pulsipher, D. J. Denniston, C. R. Krehbiel, M. G. Thomas, M. K. Petersen, D. M. Hallford, M. D. Remmenga, A. J. Roberts, et al. Effect of increasing levels of undegradable intake protein on metabolic and endocrine factors in estrous cycling beef heifers J Anim Sci, January 1, 2004; 82(1): 283 - 291. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Gill, J. L. Sharpless, K. Rado, and J. E. Hall Evidence That GnRH Decreases with Gonadal Steroid Feedback but Increases with Age in Postmenopausal Women J. Clin. Endocrinol. Metab., May 1, 2002; 87(5): 2290 - 2296. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.-L. Kottler, S. Chauvin, N. Lahlou, C. E. Harris, C. J. Johnston, J.-P. Lagarde, P. Bouchard, N. R. Farid, and R. Counis A New Compound Heterozygous Mutation of the Gonadotropin-Releasing Hormone Receptor (L314X, Q106R) in a Woman with Complete Hypogonadotropic Hypogonadism: Chronic Estrogen Administration Amplifies the Gonadotropin Defect J. Clin. Endocrinol. Metab., September 1, 2000; 85(9): 3002 - 3008. [Abstract] [Full Text] |
||||
![]() |
D. B. Gardner, J. Sebastian, and W. L. Miller Estradiol Induces and Hyperglycosylates the Receptor for Ovine Gonadotropin-Releasing Hormone Endocrinology, January 1, 2000; 141(1): 91 - 99. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |